Novo appoints interim CEO
Chairman of the Board Sten Scheibye has found a temporary replacement for Eivind Kolding as CEO of Novo A/S, while the search for a permanent replacement continues. The Chairman expects a new development in that regard this week.
%2520-%252007_08_2012%2520-%2520%2520MIK%2520ESKESTAD.jpg)
BY STEFAN SINGH KAILAY
Eivind Kolding has now officially left his position as Chief Executive Officer of Novo A/S – the parent group of Novo Nordisk and Novozymes – as the business register CVR no longer lists him as CEO as of March 1.
Allerede abonnent?Log ind her
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
Med din prøveperiode får du:
Få fuld adgang til dig og dine kollegaer
Start et gratis virksomhedsprøveabonnementRelaterede artikler
.jpg)
Novo A/S makes big investment in lab services group
For abonnenter
